Non-hypermutator cancers access driver mutations through reversals in germline mutational bias
Tuffaha, M. Z.; Castellano, D.; Colome, C. S.; Gutenkunst, R. N.; Wahl, L. M.
Show abstract
Cancer is an evolutionary disease driven by mutations in asexually-reproducing somatic cells. In asexual microbes, bias reversals in the mutation spectrum can speed adaptation by increasing access to previously undersampled beneficial mutations. By analyzing tumors from 20 tissues, along with normal tissue and the germline, we demonstrate this effect in cancer. Non-hypermutated tumors reverse the germline mutation bias and have consistent spectra across tissues. These spectra changes carry the signature of hypoxia, and they facilitate positive selection in cancer genes. Hypermutated and non-hypermutated tumors thus acquire driver mutations differently: hypermutated tumors by higher mutation rates and non-hypermutated tumors by changing the mutation spectrum to reverse the germline mutation bias.
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Copy number losses of oncogenes and gains of tumor suppressor genes generate common driver events of human cancer 97%
- Estimating growth patterns and driver effects in tumor evolution from individual samples 95%
- Mesoscale DNA Features Impact APOBEC3A and APOBEC3B Deaminase Activity and Shape Tumor Mutational Landscapes 94%
Similar papers in this journal
- Pervasive conditional selection of driver mutations and modular epistasis networks in cancer 95%
- Distinct mutational processes shape selection of MHC class I and class II mutations across primary and metastatic tumors 94%
- Integrative identification of non-coding regulatory regions driving metastatic prostate cancer 94%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.